These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9206826)

  • 1. New clues to asthma therapies.
    Vogel G
    Science; 1997 Jun; 276(5319):1643-6. PubMed ID: 9206826
    [No Abstract]   [Full Text] [Related]  

  • 2. Th-2 cytokines in allergic disease.
    Robinson DS
    Br Med Bull; 2000; 56(4):956-68. PubMed ID: 11359631
    [No Abstract]   [Full Text] [Related]  

  • 3. Inflammatory cells in asthma: mechanisms and implications for therapy.
    Hamid Q; Tulic' MK; Liu MC; Moqbel R
    J Allergy Clin Immunol; 2003 Jan; 111(1 Suppl):S5-S12; discussion S12-7. PubMed ID: 12532083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthma.
    Devillier P; Baccard N; Advenier C
    Pharmacol Res; 1999 Jul; 40(1):3-13. PubMed ID: 10378985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of asthma with drugs modifying the leukotriene pathway.
    Drazen JM; Israel E; O'Byrne PM
    N Engl J Med; 1999 Jan; 340(3):197-206. PubMed ID: 9895400
    [No Abstract]   [Full Text] [Related]  

  • 6. Pediatric Asthma--do we need more innovation for treatment?
    Riedler J
    Pediatr Allergy Immunol; 2014 Feb; 25(1):19-20. PubMed ID: 24588482
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-leukotrienes as novel anti-inflammatory treatments in asthma.
    Drazen JM
    Adv Exp Med Biol; 2002; 507():217-21. PubMed ID: 12664588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Leukotrienes and asthma. Clinical and experimental experiences with leukotriene receptor antagonists and leukotriene synthesis inhibitors].
    Henriksen AH; Bjermer L
    Tidsskr Nor Laegeforen; 1997 Feb; 117(5):647-51. PubMed ID: 9102953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukotriene receptor antagonists: clinical effects.
    Barnes N
    J R Soc Med; 1997 Apr; 90(4):200-4. PubMed ID: 9155753
    [No Abstract]   [Full Text] [Related]  

  • 10. Further evidence that leukotrienes are the major mediators of allergic constriction in human bronchi.
    Björck T; Harada Y; Dahlén B; Zetterström O; Johansson G; Rodriguez L; Hedqvist P; Dahlén SE
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():429-32. PubMed ID: 1825576
    [No Abstract]   [Full Text] [Related]  

  • 11. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part II: clinical studies with leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma.
    Devillier P; Baccard N; Advenier C
    Pharmacol Res; 1999 Jul; 40(1):15-29. PubMed ID: 10378986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis.
    Moss RB
    Ann N Y Acad Sci; 2012 Dec; 1272():49-57. PubMed ID: 23231714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pneumology. Anti-IgE antibodies in the treatment of asthma].
    Leuenberger P; Sauty A; Rochat T
    Rev Med Suisse; 2007 Jan; 3(93):56-9. PubMed ID: 17354662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-leukotrienes--a new perspective in treatment of bronchial asthma. 1. Scientific Pneumology Symposium, Cannes, 14-16 February 1997].
    Steinkamp G
    Pneumologie; 1997 Jul; 51(7):688-93. PubMed ID: 9333802
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel and emerging therapies for asthma.
    Leath TM; Singla M; Peters SP
    Drug Discov Today; 2005 Dec; 10(23-24):1647-55. PubMed ID: 16376825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TH1 and TH2 cytokine production among asthmatic children after immunotherapy.
    Huang JL; Chen LC; Yeh KW; Lin SJ; Hsieh KH; Kuo ML
    J Asthma; 2003 May; 40(3):273-9. PubMed ID: 12807171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targets for asthma therapy.
    Boushey H
    Allerg Immunol (Paris); 2000 Nov; 32(9):336-41. PubMed ID: 11195856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-asthmatic effect of schizandrin on OVA-induced airway inflammation in a murine asthma model.
    Lee MY; Seo CS; Lee NH; Ha H; Lee JA; Lee H; Lee KY; Shin HK
    Int Immunopharmacol; 2010 Nov; 10(11):1374-9. PubMed ID: 20727999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of leukotriene modifying drugs in asthma and other respiratory diseases.
    Corless JA; Paracha M
    Curr Drug Targets Inflamm Allergy; 2002 Sep; 1(3):271-5. PubMed ID: 14561192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology of bronchial inflammation: chemoreceptors as therapeutic targets.
    Marshall GD
    Allergy Asthma Proc; 2000; 21(5):309-13. PubMed ID: 11061042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.